Paul Helft
Appearances
GOBLET CELL ADENOCARCINOMA AND RESPONSE TO TREATMENT - SINGLE CENTER EXPERIENCE OF A RARE MALIGNANCY
DateMay 21, 2024Goblet cell adenocarcinoma is a rare malignancy with an incidence of 1 per 2 million people worldwide…Presenter
Speakers
Indiana UniversityIndiana University School of Medicine
